NO328019B1 - Fremgangsmate ved fastfase nukleinsyreisolering - Google Patents
Fremgangsmate ved fastfase nukleinsyreisolering Download PDFInfo
- Publication number
- NO328019B1 NO328019B1 NO19995566A NO995566A NO328019B1 NO 328019 B1 NO328019 B1 NO 328019B1 NO 19995566 A NO19995566 A NO 19995566A NO 995566 A NO995566 A NO 995566A NO 328019 B1 NO328019 B1 NO 328019B1
- Authority
- NO
- Norway
- Prior art keywords
- nucleic acid
- support material
- cells
- sample
- binding
- Prior art date
Links
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 123
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 123
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 123
- 238000000034 method Methods 0.000 title claims abstract description 107
- 238000002955 isolation Methods 0.000 title claims description 19
- 239000007790 solid phase Substances 0.000 title description 13
- 230000027455 binding Effects 0.000 claims abstract description 48
- 239000007787 solid Substances 0.000 claims abstract description 39
- 238000001514 detection method Methods 0.000 claims abstract description 26
- 230000002934 lysing effect Effects 0.000 claims abstract description 8
- 210000004027 cell Anatomy 0.000 claims description 133
- 239000000463 material Substances 0.000 claims description 101
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 43
- 150000003839 salts Chemical class 0.000 claims description 23
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 230000003321 amplification Effects 0.000 claims description 17
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 17
- 239000002245 particle Substances 0.000 claims description 16
- 238000012163 sequencing technique Methods 0.000 claims description 13
- 239000003599 detergent Substances 0.000 claims description 12
- 230000001376 precipitating effect Effects 0.000 claims description 11
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000000338 in vitro Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 210000001236 prokaryotic cell Anatomy 0.000 claims description 3
- 238000007901 in situ hybridization Methods 0.000 claims description 2
- 239000011236 particulate material Substances 0.000 claims description 2
- 239000000523 sample Substances 0.000 description 36
- 108020004414 DNA Proteins 0.000 description 26
- 230000009089 cytolysis Effects 0.000 description 17
- 239000011324 bead Substances 0.000 description 15
- 239000000872 buffer Substances 0.000 description 13
- 239000000203 mixture Substances 0.000 description 12
- 238000003752 polymerase chain reaction Methods 0.000 description 12
- 238000000926 separation method Methods 0.000 description 9
- 238000009396 hybridization Methods 0.000 description 8
- 230000009871 nonspecific binding Effects 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000012139 lysis buffer Substances 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000006249 magnetic particle Substances 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 229940016590 sarkosyl Drugs 0.000 description 5
- 108700004121 sarkosyl Proteins 0.000 description 5
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000012148 binding buffer Substances 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 3
- 239000005695 Ammonium acetate Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 229940043376 ammonium acetate Drugs 0.000 description 3
- 235000019257 ammonium acetate Nutrition 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000001821 nucleic acid purification Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 238000007399 DNA isolation Methods 0.000 description 2
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 2
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241000204031 Mycoplasma Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 108010066717 Q beta Replicase Proteins 0.000 description 2
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000003196 chaotropic effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000007614 genetic variation Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229920006158 high molecular weight polymer Polymers 0.000 description 2
- 230000005660 hydrophilic surface Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000005661 hydrophobic surface Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- -1 sheets Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241001515965 unidentified phage Species 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 241000203069 Archaea Species 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 230000009946 DNA mutation Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 102000009109 Fc receptors Human genes 0.000 description 1
- 108010087819 Fc receptors Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 241000048858 Planktothrix agardhii NIVA-CYA 116 Species 0.000 description 1
- 241000048846 Planktothrix agardhii NIVA-CYA 29 Species 0.000 description 1
- 241000530775 Planktothrix mougeotii Species 0.000 description 1
- 241000048832 Planktothrix rubescens NIVA-CYA 1 Species 0.000 description 1
- 241000048829 Planktothrix rubescens NIVA-CYA 55 Species 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 239000007997 Tricine buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000007998 bicine buffer Substances 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 238000009582 blood typing Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/1013—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Mechanical Coupling Of Light Guides (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9709728.1A GB9709728D0 (en) | 1997-05-13 | 1997-05-13 | Single step method |
| PCT/GB1998/001358 WO1998051693A1 (en) | 1997-05-13 | 1998-05-13 | Solid-phase nucleic acid isolation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO995566D0 NO995566D0 (no) | 1999-11-12 |
| NO995566L NO995566L (no) | 2000-01-11 |
| NO328019B1 true NO328019B1 (no) | 2009-11-09 |
Family
ID=10812257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19995566A NO328019B1 (no) | 1997-05-13 | 1999-11-12 | Fremgangsmate ved fastfase nukleinsyreisolering |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6617105B1 (de) |
| EP (1) | EP0988307B2 (de) |
| JP (1) | JP4175670B2 (de) |
| CN (1) | CN1187362C (de) |
| AT (1) | ATE207494T1 (de) |
| AU (1) | AU751324B2 (de) |
| CA (1) | CA2289943C (de) |
| DE (1) | DE69802191T3 (de) |
| DK (1) | DK0988307T4 (de) |
| ES (1) | ES2163865T5 (de) |
| GB (1) | GB9709728D0 (de) |
| NO (1) | NO328019B1 (de) |
| PT (1) | PT988307E (de) |
| WO (1) | WO1998051693A1 (de) |
Families Citing this family (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9425138D0 (en) * | 1994-12-12 | 1995-02-08 | Dynal As | Isolation of nucleic acid |
| ATE396279T1 (de) * | 1998-02-02 | 2008-06-15 | Qiagen North American Holdings | Verfahren zur isolierung, amplifizierung und charakterisierung von dns |
| US6387632B2 (en) | 1998-06-11 | 2002-05-14 | Hitachi, Ltd. | Polynucleotide separation method and apparatus therefor |
| US6093370A (en) * | 1998-06-11 | 2000-07-25 | Hitachi, Ltd. | Polynucleotide separation method and apparatus therefor |
| US6291179B1 (en) * | 1998-09-10 | 2001-09-18 | Whatman Plc | Product and method for separation of a sample containing multiple sources of genetic material using a solid medium |
| US7790865B1 (en) * | 1999-02-02 | 2010-09-07 | Qiagen North American Holdings, Inc | Eluting reagents, methods and kits for isolating DNA |
| GB0001450D0 (en) | 2000-01-21 | 2000-03-08 | Genpoint As | Cell isolation method |
| GB0008787D0 (en) | 2000-04-10 | 2000-05-31 | Norsk Naeringsmiddelforskning | A method of cell detection |
| GB0013658D0 (en) * | 2000-06-05 | 2000-07-26 | Dynal Asa | Nucleic acid isolation |
| AU1548802A (en) * | 2000-06-21 | 2002-01-02 | Digene Corp | Universal collection medium |
| PT102491B (pt) * | 2000-07-10 | 2003-02-28 | Inst Superior Tecnico | Processo para producao e purificacao de dna plasmidico |
| AU2008201675B2 (en) * | 2001-05-14 | 2012-06-07 | Zygem Corporation Limited | Thermostable Proteinases From Thermophilic Bacteria |
| NZ511680A (en) * | 2001-05-14 | 2004-07-30 | Univ Waikato | Method for preparing nucleic acid or DNA samples and a DNA extraction process using thermophilic proteases |
| DE10129815A1 (de) | 2001-06-24 | 2003-01-09 | Profos Ag | Verfahren zur Aufreinigung von Bakterienzellen und Zellbestandteilen |
| DE10230147A1 (de) * | 2001-10-09 | 2004-01-15 | Profos Ag | Verfahren zur unspezifischen Anreicherung von Bakterienzellen |
| US20050032105A1 (en) * | 2001-10-12 | 2005-02-10 | Bair Robert Jackson | Compositions and methods for using a solid support to purify DNA |
| US7192560B2 (en) * | 2001-12-20 | 2007-03-20 | 3M Innovative Properties Company | Methods and devices for removal of organic molecules from biological mixtures using anion exchange |
| US7347976B2 (en) * | 2001-12-20 | 2008-03-25 | 3M Innovative Properties Company | Methods and devices for removal of organic molecules from biological mixtures using a hydrophilic solid support in a hydrophobic matrix |
| WO2003057910A2 (en) | 2002-01-08 | 2003-07-17 | Roche Diagnostics Gmbh | Use of silica material in an amplification reaction |
| CN1230531C (zh) * | 2002-12-09 | 2005-12-07 | 清华大学 | 从样品中分离细胞粒子的方法 |
| CN1223680C (zh) * | 2002-12-10 | 2005-10-19 | 清华大学 | 扩增靶细胞或病毒的核酸的方法 |
| CN100494399C (zh) | 2003-06-30 | 2009-06-03 | 清华大学 | 一种基于dna芯片的基因分型方法及其应用 |
| NZ545469A (en) * | 2003-09-12 | 2009-11-27 | Biocontrol Systems Inc | Methods, compositions, and kits for the concentration and detection of microorganisms without a separate DNA extraction step |
| JP2007516729A (ja) * | 2003-12-30 | 2007-06-28 | シグマ−アルドリッチ・カンパニー | 酵素消化による核酸の迅速な調製 |
| JP4831725B2 (ja) * | 2004-02-13 | 2011-12-07 | 栄研化学株式会社 | 簡易的核酸抽出法 |
| US7419798B2 (en) | 2004-10-19 | 2008-09-02 | Zybac Llc | Rapid and sensitive detection of bacteria in blood products, urine, and other fluids |
| US20080305538A1 (en) * | 2004-10-19 | 2008-12-11 | Medical Innovations International, Inc. | Rapid and Sensitive Detection of Bacteria in Blood Products, Urine, and Other Fluids |
| DE102005002342A1 (de) | 2005-01-18 | 2006-07-20 | GEN-Institut für Angewandte Laboranalysen GmbH | Verfahren sowie Kit zur Sterilisierung von Mikroorganismen enthaltenden Flüssigkeiten |
| US20060166223A1 (en) * | 2005-01-26 | 2006-07-27 | Reed Michael W | DNA purification and analysis on nanoengineered surfaces |
| US8615368B2 (en) * | 2005-03-10 | 2013-12-24 | Gen-Probe Incorporated | Method for determining the amount of an analyte in a sample |
| US20060223071A1 (en) * | 2005-04-01 | 2006-10-05 | Wisniewski Michele E | Methods, compositions, and kits for detecting nucleic acids in a single vessel |
| EP1712284B1 (de) * | 2005-04-15 | 2012-10-10 | Samsung Electronics Co., Ltd. | Methode zur Zelltrennung mit Benutzung hydrophober fester Träger |
| US20060257907A1 (en) * | 2005-04-19 | 2006-11-16 | The Regents Of The University Of California | Packed bed for nucleic acid capture and amplification |
| JP2006311803A (ja) * | 2005-05-06 | 2006-11-16 | Hitachi High-Technologies Corp | 核酸精製方法、及び核酸精製器具 |
| KR100682945B1 (ko) * | 2005-05-24 | 2007-02-15 | 삼성전자주식회사 | 상 분리를 이용한 세포 분리 방법 및 키트 |
| US20070026435A1 (en) * | 2005-07-28 | 2007-02-01 | Polysciences, Inc. | Hydroxysilane functionalized magnetic particles and nucleic acid separation method |
| GB0525231D0 (en) * | 2005-12-12 | 2006-01-18 | Genpoint As | Method |
| CA2533052C (en) * | 2006-01-16 | 2016-02-09 | Yousef Haj-Ahmad | Isolating both free and protein associated dna |
| KR100829585B1 (ko) * | 2006-04-07 | 2008-05-14 | 삼성전자주식회사 | 표적 세포 분리 및 신속한 핵산 분리 방법 및 장치 |
| US7608399B2 (en) * | 2006-06-26 | 2009-10-27 | Blood Cell Storage, Inc. | Device and method for extraction and analysis of nucleic acids from biological samples |
| KR100790880B1 (ko) * | 2006-07-05 | 2008-01-02 | 삼성전자주식회사 | 자성 비드가 결합되어 있는 소수성 다공성 중합체가 벽면에결합되어 있는 마이크로채널 또는 마이크로챔버를포함하는 미세유동장치 및 그를 이용하는 방법 |
| WO2008017097A1 (en) * | 2006-08-10 | 2008-02-14 | Merck Patent Gmbh | Method for isolating cells |
| US8158411B2 (en) * | 2006-08-21 | 2012-04-17 | Samsung Electronics Co., Ltd. | Method of separating microorganism using nonplanar solid substrate and device for separating microorganism using the same |
| KR100917465B1 (ko) * | 2006-08-21 | 2009-09-14 | 삼성전자주식회사 | 비평면 형상의 고체 지지체를 이용하여 미생물을 분리하는방법 및 미생물분리 장치 |
| US20080044880A1 (en) * | 2006-08-21 | 2008-02-21 | Samsung Electronics Co., Ltd. | Method of and apparatus for separating microorganisms from sample using electrodialysis and microorganism capturing means |
| US20080070282A1 (en) | 2006-08-21 | 2008-03-20 | Samsung Electronics Co., Ltd. | Method and device for obtaining or amplifying nucleic acid from a cell using a nonplanar solid substrate |
| KR100862660B1 (ko) | 2006-09-25 | 2008-10-10 | 삼성전자주식회사 | 단일 비드에 의한 핵산의 분리 및 정제 방법 및 장치 |
| US20080124777A1 (en) * | 2006-11-29 | 2008-05-29 | Canon U.S. Life Sciences, Inc. | Method for releasing genetic material from solid phase |
| US20080131954A1 (en) * | 2006-11-30 | 2008-06-05 | Canon U.S. Life Sciences, Inc. | Method of Separating Target DNA from Mixed DNA |
| JP2008167722A (ja) | 2007-01-15 | 2008-07-24 | Konica Minolta Medical & Graphic Inc | 磁性支持体上での加熱による核酸単離方法 |
| US20100048410A1 (en) * | 2007-03-22 | 2010-02-25 | Advanced Liquid Logic, Inc. | Bead Sorting on a Droplet Actuator |
| WO2008134470A2 (en) * | 2007-04-25 | 2008-11-06 | 3M Innovative Properties Company | Methods for nucleic acid amplification |
| EP2140002A1 (de) * | 2007-04-25 | 2010-01-06 | 3M Innovative Properties Company | Zusammensetzungen, verfahren und vorrichtungen zur isolierung von biologischem material |
| WO2009117167A1 (en) * | 2008-01-02 | 2009-09-24 | Blood Cell Storage, Inc. | Devices and processes for nucleic acid extraction |
| FR2926560A1 (fr) * | 2008-01-21 | 2009-07-24 | Millipore Corp | Procede d'extraction et de purification d'acides nucleiques sur membrane |
| BRPI0908128A2 (pt) * | 2008-02-12 | 2015-08-04 | Novartis Ag | Método para isolamento de ácido nucleicos apoptóticos ou fetais livres de células |
| US7867713B2 (en) * | 2008-04-21 | 2011-01-11 | Lawrence Livermore National Security, Llc | Polymerase chain reaction system using magnetic beads for analyzing a sample that includes nucleic acid |
| CA2742598A1 (en) * | 2008-11-04 | 2010-05-14 | Blood Cell Storage, Inc. | Nucleic acid extraction on curved glass surfaces |
| US8409801B2 (en) * | 2009-02-04 | 2013-04-02 | Covaris, Inc. | Method and apparatus for material separation using acoustic energy |
| WO2010089098A1 (de) | 2009-02-05 | 2010-08-12 | Deklatec Gmbh | Verfahren und mittel für die tuberkulose diagnostik |
| TWI407994B (zh) | 2009-10-22 | 2013-09-11 | Ind Tech Res Inst | 分離核酸的方法、試劑及套組 |
| GB2475226A (en) | 2009-11-03 | 2011-05-18 | Genetic Analysis As | Universal Prokaryote 16S ribosome PCR primer pair |
| US8202693B2 (en) * | 2009-11-24 | 2012-06-19 | Omega Bio-Tek, Inc. | Method of isolation of nucleic acids |
| GB201011152D0 (en) * | 2010-07-02 | 2010-08-18 | Microsens Medtech Ltd | Capture of micro-organisms |
| DE102010031401A1 (de) * | 2010-07-15 | 2012-01-19 | Aj Innuscreen Gmbh | Verfahren zur Anreicherung von Bakterien, Viren sowie Zellen und zur nachfolgenden Nukleinsäureisolierung |
| WO2012024695A1 (en) * | 2010-08-20 | 2012-02-23 | Life Technologies Corporation | Magnetic beads having surface glycoconjugates and use thereof |
| EP2619320B1 (de) * | 2010-09-24 | 2015-11-18 | Qiagen GmbH | Reagenz zum aufschluss von zellmaterial mit vollständig integriertem internem standard |
| WO2012075508A2 (en) * | 2010-12-03 | 2012-06-07 | Blood Cell Storage, Inc. | Processes for isolating microorganisms |
| GB201021399D0 (en) | 2010-12-16 | 2011-01-26 | Genetic Analysis As | Oligonucleotide probe set and methods of microbiota profiling |
| GB201021397D0 (en) | 2010-12-16 | 2011-01-26 | Genetic Analysis As | Diagnosis of Crohn's disease |
| GB201102693D0 (en) | 2011-02-16 | 2011-03-30 | Genetic Analysis As | Method for identifying neonates at risk for necrotizing enterocolitis |
| US8629264B2 (en) | 2011-05-19 | 2014-01-14 | Blood Cell Storage, Inc. | Gravity flow fluidic device for nucleic acid extraction |
| US9416356B2 (en) | 2013-03-15 | 2016-08-16 | Abbott Molecular Inc. | Compositions and methods for nucleic acid extraction |
| EP3187595B1 (de) * | 2015-12-30 | 2019-01-16 | Fundación Gaiker | Verfahren zum nachweis von legionella spp. stämme in umweltproben auf basis von loop-vermittelter isothermaler amplifikation (lamp), nachweisreagens und primersets. |
| GB201617519D0 (en) | 2016-10-14 | 2016-11-30 | Genetic Analysis As | A companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant |
| JP7317821B2 (ja) | 2017-07-17 | 2023-07-31 | スマートディーエヌエー ピーティーワイ エルティーディー | ディスバイオシスを診断する方法 |
| GB201712459D0 (en) | 2017-08-02 | 2017-09-13 | Norges Miljø-Og Biovitenskapelige Univ | Treatment or prevention of gastrointestinal dysbiosis |
| CN111712566A (zh) * | 2018-02-08 | 2020-09-25 | 应用干细胞有限公司 | 用于筛选靶基因变体的方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4001197A (en) | 1975-06-12 | 1977-01-04 | Sala Magnetics, Inc. | Magnetic separation method |
| US5077192A (en) | 1988-10-25 | 1991-12-31 | The General Hospital Corporation | Method of detecting antigenic, nucleic acid-containing macromolecular entities |
| US5234809A (en) * | 1989-03-23 | 1993-08-10 | Akzo N.V. | Process for isolating nucleic acid |
| NL8900725A (nl) | 1989-03-23 | 1990-10-16 | Az Univ Amsterdam | Werkwijze en combinatie van middelen voor het isoleren van nucleinezuur. |
| IE64040B1 (en) | 1989-06-15 | 1995-06-28 | Akzo Nv | Method for determining nucleic acid |
| ATE147792T1 (de) | 1989-11-30 | 1997-02-15 | Pharmacia Biotech Ab | Neues verfahren zum nachweis einer spezifischen nukleinsäuresequenz in einer zellprobe |
| GB9003253D0 (en) * | 1990-02-13 | 1990-04-11 | Amersham Int Plc | Precipitating polymers |
| US5652141A (en) * | 1990-10-26 | 1997-07-29 | Oiagen Gmbh | Device and process for isolating nucleic acids from cell suspension |
| DE4034036C2 (de) | 1990-10-26 | 1994-03-03 | Diagen Inst Molekularbio | Vorrichtung und Verfahren zur Isolierung von Nukleinsäuren aus Zellsuspensionen |
| US5491068A (en) * | 1991-02-14 | 1996-02-13 | Vicam, L.P. | Assay method for detecting the presence of bacteria |
| GB9107124D0 (en) | 1991-04-05 | 1991-05-22 | Dynal As | Chemical process |
| GB9425138D0 (en) * | 1994-12-12 | 1995-02-08 | Dynal As | Isolation of nucleic acid |
| DE19520398B4 (de) | 1995-06-08 | 2009-04-16 | Roche Diagnostics Gmbh | Magnetisches Pigment |
| GB9518156D0 (en) * | 1995-09-06 | 1995-11-08 | Medical Res Council | Method of isolating cells |
-
1997
- 1997-05-13 GB GBGB9709728.1A patent/GB9709728D0/en active Pending
-
1998
- 1998-05-13 AT AT98921592T patent/ATE207494T1/de active
- 1998-05-13 US US09/423,796 patent/US6617105B1/en not_active Expired - Fee Related
- 1998-05-13 WO PCT/GB1998/001358 patent/WO1998051693A1/en active IP Right Grant
- 1998-05-13 DE DE69802191T patent/DE69802191T3/de not_active Expired - Lifetime
- 1998-05-13 CA CA002289943A patent/CA2289943C/en not_active Expired - Fee Related
- 1998-05-13 AU AU74387/98A patent/AU751324B2/en not_active Ceased
- 1998-05-13 JP JP54892198A patent/JP4175670B2/ja not_active Expired - Fee Related
- 1998-05-13 CN CNB98806278XA patent/CN1187362C/zh not_active Expired - Fee Related
- 1998-05-13 EP EP98921592A patent/EP0988307B2/de not_active Expired - Lifetime
- 1998-05-13 ES ES98921592T patent/ES2163865T5/es not_active Expired - Lifetime
- 1998-05-13 PT PT98921592T patent/PT988307E/pt unknown
- 1998-05-13 DK DK98921592T patent/DK0988307T4/da active
-
1999
- 1999-11-12 NO NO19995566A patent/NO328019B1/no not_active IP Right Cessation
-
2003
- 2003-06-11 US US10/458,913 patent/US7560228B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69802191T2 (de) | 2002-06-06 |
| DK0988307T3 (da) | 2002-02-18 |
| ATE207494T1 (de) | 2001-11-15 |
| US20040072215A1 (en) | 2004-04-15 |
| CA2289943A1 (en) | 1998-11-19 |
| EP0988307A1 (de) | 2000-03-29 |
| PT988307E (pt) | 2002-02-28 |
| DK0988307T4 (da) | 2007-10-22 |
| AU751324C (en) | 1998-12-08 |
| AU751324B2 (en) | 2002-08-15 |
| EP0988307B2 (de) | 2007-06-27 |
| ES2163865T5 (es) | 2008-02-01 |
| JP4175670B2 (ja) | 2008-11-05 |
| NO995566L (no) | 2000-01-11 |
| US7560228B2 (en) | 2009-07-14 |
| DE69802191D1 (de) | 2001-11-29 |
| WO1998051693A1 (en) | 1998-11-19 |
| CN1187362C (zh) | 2005-02-02 |
| DE69802191T3 (de) | 2008-02-07 |
| NO995566D0 (no) | 1999-11-12 |
| ES2163865T3 (es) | 2002-02-01 |
| EP0988307B1 (de) | 2001-10-24 |
| AU7438798A (en) | 1998-12-08 |
| CA2289943C (en) | 2009-05-12 |
| CN1260800A (zh) | 2000-07-19 |
| JP2002507116A (ja) | 2002-03-05 |
| GB9709728D0 (en) | 1997-07-02 |
| US6617105B1 (en) | 2003-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU751324B2 (en) | Solid-phase nucleic acid isolation | |
| US8202693B2 (en) | Method of isolation of nucleic acids | |
| CA2207608C (en) | Isolation of nucleic acid | |
| US6291248B1 (en) | Nucleic acid purification and process | |
| AU2006212392B2 (en) | Method for isolating nucleic acids, the nucleic acids being immobilised on a matrix at an increased temperature | |
| CA2410888C (en) | Nucleic acid isolation | |
| US6582922B1 (en) | Method of extracting nucleic acids using particulate carrier | |
| AU2001260507A1 (en) | Nucleic acid isolation | |
| JP2006517225A (ja) | 核酸抽出のための生物学的試料の化学処理および該処理用のキット | |
| JP3979996B2 (ja) | 固体支持体を使用してｒｎａを精製するための組成物および方法 | |
| RU2766005C2 (ru) | Система очистки нуклеиновой кислоты с использованием одного буферного раствора для промывания и элюирования | |
| CA2315257A1 (en) | Method for isolating short and long-chain nucleic acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |